Table 4.
Subject | t Value | P Value | No. of (Total) Trials |
---|---|---|---|
BA | −0.95 | 0.34 | 2,051 |
KE | −0.04 | 0.97 | 2,132 |
BB | −2.24 | <0.05 | 1,787 |
GC | −1.35 | 0.18 | 2,078 |
MH | 0.31 | 0.76 | 1,943 |
EJ | 1.05 | 0.29 | 2,135 |
HP | 1.20 | 0.23 | 2,117 |
Subject | t Value | P Value | No. of (Total) Trials |
---|---|---|---|
BA | −0.95 | 0.34 | 2,051 |
KE | −0.04 | 0.97 | 2,132 |
BB | −2.24 | <0.05 | 1,787 |
GC | −1.35 | 0.18 | 2,078 |
MH | 0.31 | 0.76 | 1,943 |
EJ | 1.05 | 0.29 | 2,135 |
HP | 1.20 | 0.23 | 2,117 |